Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Consensus Conference
  • Published:

Immunological research in clinical psychiatry: report on the consensus debate during the 7th expert meeting on psychiatry and immunology

Abstract

There is convincing evidence that cytokines are involved in the physiology and pathophysiology of brain function and interact with different neurotransmitter and neuroendocrine pathways. The possible involvement of the immune system in the neurobiological mechanisms that underlie psychiatric disorders has attracted increasing attention in recent years. Thus in the last decade, numerous clinical studies have demonstrated dysregulated immune functions in patients with psychiatric disorders. Such findings formed the basis of the 7th Expert Meeting on Psychiatry and Immunology in Muenster, Germany, where a consensus symposium was held to consider the strengths and weaknesses of current research in psychoneuroimmunology. Following a general overview of the field, the following topics were discussed: (1) methodological problems in laboratory procedures and recruitment of clinical samples; (2) the importance of pre-clinical research and animal models in psychiatric research; (3) the problem of statistical vs biological relevance. It was concluded that, despite a fruitful proliferation of research activities throughout the last decade, the continuous elaboration of methodological standards including the implementation of hypothesis-driven research represents a task that is likely to prove crucial for the future development of immunology research in clinical psychiatry.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lehmann-Facius H . Liquoruntersuchungen bei destruktiven Erkrankungen des Nervensystems, besonders bei Schizophrenien Neurol Psychiatrie 1937; 157: 109–115

    Article  Google Scholar 

  2. Stein M, Miller AH, Trestman RL . Depression, the immune system, and health and illness. Findings in search of meaning Arch Gen Psychiatry 1991; 48: 171–177

    Article  CAS  Google Scholar 

  3. Kirch DG . Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal Schizophr Bull 1993; 19: 355–370

    Article  CAS  Google Scholar 

  4. Dantzer R, Wollman E, Vitkovic L, Yirmiya R . Cytokines and depression: fortuitous or causative association? Mol Psychiatry 1999; 4: 328–332

    Article  CAS  Google Scholar 

  5. Capuron L, Ravaud A, Dantzer R . Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alpha-2b therapy J Clin Oncol 2000; 18: 2143–2151

    Article  CAS  Google Scholar 

  6. Villemain F, Chatenoud L, Galinowski A, Homo-Delarche F, Ginestet D, Loo H et al. Aberrant T-cell mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production Am J Psychiatry 1989; 146: 609–616

    Article  CAS  Google Scholar 

  7. Ganguli R, Brar JS, Chengappa KNR, DeLeo M, Yang ZW, Shurin G, Rabin BS . Mitogen-stimulated interleukin-2 production in never-medicated, first episode schizophrenic patients Arch Gen Psychiatry 1995; 52: 668–671

    Article  CAS  Google Scholar 

  8. Arolt V, Rothermundt M, Wandinger KP, Kirchner H . Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment Mol Psychiatry 2000; 5: 150–158

    Article  CAS  Google Scholar 

  9. Rothermundt M, Arolt V, Leadbeater J, Peters M, Rudolf S, Kirchner H . Cytokine production in unmedicated and treated schizophrenic patients Neuroreport 2000; 11: 3385–3388

    Article  CAS  Google Scholar 

  10. Rapaport MH, McAllister CG, Pickar D, Tamarkin L, Kirch DG, Paul SM . CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers Schizophr Res 1997; 25: 123–129

    Article  CAS  Google Scholar 

  11. Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH . Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients Am J Psychiatry 1993; 150: 1408–1410

    Article  CAS  Google Scholar 

  12. McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME et al. Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status Am J Psychiatry 1995; 152: 1291–1297

    Article  CAS  Google Scholar 

  13. Rapaport MH, McAllister CG, Pickar D, Nelson DL, Paul SM . Elevated levels of soluble interleukin-2 receptors in schizophrenia Arch Gen Psychiatry 1989; 46: 291–292

    Article  CAS  Google Scholar 

  14. Rapaport MH, Lohr JB . Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia Acta Psychiatr Scand 1994; 90: 311–315

    Article  CAS  Google Scholar 

  15. Schwarz MJ, Riedel M, Gruber R, Ackenheil M, Muller N . Antibodies to heat shock proteins in schizophrenic patients: implications for the mechanism of the disease Am J Psychiatry 1999; 156: 1103–1104

    CAS  PubMed  Google Scholar 

  16. Müller N, Riedel M, Hadjamu M, Schwarz MJ, Ackenheil M, Gruber R . Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood–brain barrier permeability in schizophrenia Am J Psychiatry 1999; 156: 634–636

    PubMed  Google Scholar 

  17. Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kuhn M, Schuld A, Pollmacher T . Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis J Psychiatr Res 1999; 33: 407–418

    Article  CAS  Google Scholar 

  18. Pollmacher T, Haack M, Schuld A, Kraus T, Hinze-Selch D . Effects of antipsychotic drugs on cytokine networks J Psychiatr Res 2000; 34: 369–382

    Article  CAS  Google Scholar 

  19. Yolken RH, Karlsson H, Yee F, Johnston-Wilson NL, Torrey EF . Endogenous retroviruses and schizophrenia Brain Res Brain Res Rev 2000; 31: 193–199

    Article  CAS  Google Scholar 

  20. van West D, Maes M . Activation of the inflammatory response system: a new look at the etiopathogenesis of major depression Neuroendocrinol Lett 1999; 20: 11–17

    CAS  PubMed  Google Scholar 

  21. Licinio J, Wong ML . The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection Mol Psychiatry 1999; 4: 317–327

    Article  CAS  Google Scholar 

  22. Prolo P, Licinio J . Cytokines in affective disorders and schizophrenia: new clinical and genetic findings Mol Psychiatry 1999; 4: 396

    Article  CAS  Google Scholar 

  23. Leonard BE . The immune system, depression and the action of antidepressants Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 767–780

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V Arolt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arolt, V., Rothermundt, M., Peters, M. et al. Immunological research in clinical psychiatry: report on the consensus debate during the 7th expert meeting on psychiatry and immunology. Mol Psychiatry 7, 822–826 (2002). https://doi.org/10.1038/sj.mp.4001115

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001115

Keywords

Search

Quick links